# In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults

> **NCT00144352** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 540 (—)

## Conditions studied

- Malaria
- HIV
- AIDS

## Interventions

- **DRUG:** sulfadoxine-pyrimethamine

## Key facts

- **NCT ID:** NCT00144352
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2004-07
- **Target enrollment:** 540 (—)
- **Last updated:** 2005-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144352, "In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00144352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*